Main > ONCOLOGY (**) > Lung>NSCLC>EGFR+>MET>*** > Treatment > Co: UK. A. Osimertinib > (*) JP Approval Date: 2022. 08.25

---

(*) JP Approval Date: 2022. 08.25's products
This section has no products